ACDIMA, Lincoln, Compass Capital eyeing United Pharma IV Solutions acquisition

M&A WATCH- US investment fund Lincoln Investment, ACDIMA, and a Compass Capital fund are going head-to-head in a race to acquire United Pharma IV Solutions, Al Mal reports. Al Mal says Lincoln’s bid is in the EGP 450-540 mn range, while Compass Capital has offered EGP 450-500 mn, but negotiations are still ongoing. United Pharma favors ACDIMA as a suitor, as “a state company that would make IV solutions available in public hospitals,” Chairman Abdallah Mahfouz tells Al Mal.